Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
The FDA approved Eli Lilly's (LLY) obesity drug for the treatment of sleep apnea, sending rival ResMed (RMD) stock lower ...
ResMed's Chief Medical Officer has suggested doctors will prescribe using both drugs and devices such as his company makes together to help sleep apnea suffers. Shares of ResMed (RMD) and Inspire ...
ResMed has established itself as a key player in the sleep and respiratory care market, with a primary focus on devices for sleep apnea and other respiratory conditions. The company's consistent ...
My task today was to hunt for ASX companies that share some of those traits. Some of the points I touched on in the Monster ...
ResMed Inc. (RMD), based in San Diego ... to enhancing the quality of life for individuals suffering from sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory ailments ...
Aside from the $3500 starting price, there’s one common complaint about Apple Vision Pro that most customers experience. Apple ...
A medical vendor with decades of experience making medical-grade head gear has revealed a new strap to make the Apple Vision ...